The influence of China's pollution emissions trading system on the listed companies' export products' quality.

The pollution emissions trading system (PETS) pilot policy is China's first large-scale implementation of market-based environmental regulations; whether it can reduce pollution emissions and improve the export competitiveness is crucial for China to achieve the coordinated development of environment and economy. Based on the panel data of Chinese listed companies from 2003 to 2016, this paper considers the PETS pilot policy as a natural experiment, and investigates the impact of the policy on export products' quality using the difference-in-difference (DID) model. We found that (1) the PETS pilot policy has significantly improved the quality of listed companies' export products. (2) Technological innovation plays a partial intermediary role in promoting export products' quality by the PETS pilot policy; the "Porter Hypothesis" has been verified in China. (3) When the listed companies with different characteristics face the PETS pilot policy, the quality of their export products will show a differentiated development trend. Based on the above research conclusions, we put forward corresponding recommendations for China to realize the coordinated development of environment and trade.

Molecular dynamics simulation study of covalently bound hybrid coagulants (CBHyC): Molecular structure and coagulation mechanisms.

Covalently-bound organic silicate-aluminum hybrid coagulants (CBHyC) have been shown to efficiently remove low molecular weight organic contaminants from wastewater. However, the interaction dynamics and motivations during the coagulation of contaminant molecules by CBHyC are limited. In this study, a molecular dynamics (MD) simulation showed that CBHyC forms core-shell structure with the aliphatic carbon chains gather inside as a core and the hydrophilic quaternary ammonium-Si-Al complexes disperse outside as a shell. This wrapped structure allowed the coagulant to diffuse into solutions easily and capture target contaminants. The adsorption of anionic organic contaminants (e.g., diclofenac) onto the CBHyC aggregates was driven equally by van der Waals forces and electrostatic interactions. Cationic organic contaminants (e.g., tetracycline) were seldom bound to CBHyC because of substantial repulsive forces between cationic molecules and CBHyC. Neutrally-charged organic molecules were generally bound through hydrophobic interactions. For adenine and thymine deoxynucleotide, representatives of antibiotic resistance genes, van der Waals forces and electrostatic interaction became the dominant driving force with further movement for adenine and thymine, respectively. Driving forces between target contaminant and coagulant directly affect the size and stability of formed aggregate, following the coagulation efficiency of wastewater treatment. The findings of this study enrich the database of aggregation behavior between low molecular weight contaminants and CBHyC and contribute to further and efficient application of CBHyC in wastewater treatment.

Author Correction: Actinia-like multifunctional nanocoagulant for single-step removal of water contaminants.

In the version of the Supplementary Information file originally published with this Article, the images used for Supplementary Fig. 4 were incorrect and have now been replaced. This does not affect the results of the Article.

Actinia-like multifunctional nanocoagulant for single-step removal of water contaminants.

Current technologies for water purification are limited by their contaminant-specific removal capability, requiring multiple processes to meet water quality objectives. Here we show an innovative biomimetic micellar nanocoagulant that imitates the structure of Actinia, a marine predator that uses its tentacles to ensnare food, for the removal of an array of water contaminants with a single treatment step. The Actinia-like micellar nanocoagulant has a core-shell structure and readily disperses in water while maintaining a high stability against aggregation. To achieve effective coagulation, the nanocoagulant everts its configuration, similar to Actinia. The shell hydrolyses into 'flocs' and destabilizes and enmeshes colloidal particles while the core is exposed to water, like the extended tentacles of Actinia, and adsorbs the dissolved contaminants. The technology, with its ability to remove a broad spectrum of contaminants and produce high-quality water, has the potential to be a cost-effective replacement for current water treatment processes.

SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu.

Previously, we reported that SV40 T/t-common polypeptide, which contains the NH(2)-terminal common domain of SV40 large T and small t antigens, can repress HER2/neu (also known as erbB-2) expression and consequently suppress the tumorigenic potential of the HER2/neu-overexpressing ovarian carcinoma cells. Here we report that T/t-common could specifically induce apoptosis in HER2/neu-overexpressing human cancer cell lines but not in nontransformed cell lines and HER2/neu low-expressing human cancer cell lines. The ability of T/t-common to induce apoptosis in HER2/neu-overexpressing cancer cells was derived from its ability to inhibit HER2/neu because reexpression of a large amount of HER2/neu could block apoptosis induced by T/t-common. T/t-common expression in HER2/neu-overexpressing SK-OV-3 cancer cells led to down-regulation of Bcl-2 and Bcl-X(L), and overexpression of Bcl-2 could inhibit the ability of T/t-common to induce apoptosis in these cells. Therefore, the apoptosis-inducing activity of T/t-common is related to its ability to inhibit Bcl-2 expression in HER2/neu-overexpressing cancer cells. Consistent with the apoptosis-inducing activity of T/t-common, we found that T/t-common could specifically inhibit the soft-agarose colony-forming ability of the HER2/neu-overexpressing human cancer cell lines but not that of the HER2/neu low-expressing human cancer cell lines. Finally, we showed that T/t-common could specifically sensitize HER2/neu-overexpressing human cancer cell lines, but not HER2/neu low-expressing human cancer cell lines, to chemotherapeutic agent etoposide. Together, these data suggest that T/t-common alone or in combination with chemotherapy may provide a new approach for treatment of cancers that overexpress HER2/neu.

Molecular insights into the mechanism and the efficiency-structure relationship of phosphorus removal by coagulation.

Types and structures of phosphorus compounds influence the removal of phosphorus by coagulation. Until now, the molecular-level interaction between coagulants and phosphorus (especially organophosphates) and the relationship between removal efficiency and phosphorus structure have not been clear. This work investigated the removal of phosphorus with different structures using conventional coagulants (poly aluminum chloride (PACl) and polymerized ferric sulfate (PFS)) and a novel covalently-bound inorganic-organic hybrid coagulant (CBHyC). CBHyC removed more than 98% of phosphate and most of organophosphates, had more stable performance than PACl and PFS, and was less affected by pH, initial phosphorus concentration, and co-occurring materials. Molecular dynamics simulation demonstrated that CBHyC removed phosphorus mainly through electrostatic attraction and hydrophobic interaction. Furthermore, this work established QSAR (quantitative structure activity relationship) models for removal efficiency and organophosphate structure for the first time. The model showed that atomic charges of phosphorus atoms (QP) and hydrogen atoms (QH+) in the system and the energy gap (ΔEMO) affected electronegativity and hydrophobicity, thus influencing organophosphate removal efficiency. The model had high fitting precision and good predictive ability and has the potential to greatly reduce the cost of optimizing processes and conditions for phosphorus removal.